Subscribe to Newsletter

September 2020 Issue of The Medicine Maker

In September’s issue of The Small Molecule Manufacturer, we take a deep-dive into the history of Indian pharma and ask industry experts how the country is adapting to the changes caused by the COVID-19 pandemic. Meanwhile, in The Next Big Thing, we examine the pros and cons of continuous manufacturing and discover how the API manufacturing process can be de-risked. We also sit down with JoyL Silva, General Manager at Pfizer CentreOne.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Manufacture Ingredients

Old-Time Medicine

| Stephanie Vine

Can a medieval medicament find use as a modern antibacterial?
Manufacture Ingredients

Biologically Active Excipients?

| Maryam Mahdi

Newly published research suggests that some excipients may be more "active" than previously thought.
Business & Regulation Business Practice

Business-in-Brief

| James Strachan

New forays into the pharma space and a billion-dollar discovery deal… What’s new in business?

Business & Regulation Trends & Forecasts

The Key to Competition

| James Strachan

Researchers identify several factors associated with shorter marketing exclusivity periods.
Business & Regulation Small Molecules

Sayonara, Serendipity

| James Strachan

How can small molecule "degraders" help target disease-causing proteins?
Discovery & Development Drug Discovery

New Options in Pain Management

| Maryam Mahdi

Acetaminophen derivatives could offer patients a safer alternative to common pain management treatments.
Manufacture Standards & Regulation

A Blossoming Market

| Maryam Mahdi

How is the Indian pharmaceutical industry adapting to meet new demands?
Manufacture Small Molecules

A Year of Challenge and Opportunity

| Maryam Mahdi

How do we manage the fallout caused by the COVID-19 pandemic?
Manufacture Technology and Equipment

The Trends Behind the Tech

| Maryam Mahdi

Richard Stedman from ACG Engineering outlines the trends driving change in the Indian pharmaceutical equipment industry.
Manufacture Technology and Equipment

Breaking With Tradition

| Mark Muldowney

Is continuous manufacturing worth the investment for pharma companies?
Manufacture Ingredients

The Crystal Maze

| David Pearson

How can manufacturers avoid frustrating and inadvertent changes to the solid forms of APIs?

Business & Regulation Business Practice

Creating Value at All Levels

| Maryam Mahdi

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.

Other issues of 2020